Latest Breaking News On - Shabir hasham - Page 1 : comparemela.com

Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Ad hoc announcement pursuant to Art. 53 LR A conference call will be held on April 25, 2024, at 14:30 CEST / 13:30 BST / 08:30 EDT. Details are at the end of this news release. Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May 2023 financial key figures: Revenue from contracts with customers of CHF 103.4 million (2022: CHF 7.5 million) Net result of CHF 54.8 million (2022: CHF -71.1 million) Cash flow from operating

Italy
United-states
Highbridge
Somerset
United-kingdom
Spain
Pratteln
Switzerland-general
Switzerland
France
Austria
China

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May

Santhera Pharmaceuticals Holding AG: Santhera Announces Preliminary Unaudited 2023 Annual Results and Provides Corporate Update Ahead of Full Report Publication in May
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

China
Austria
France
United-kingdom
Germany
Spain
Pratteln
Switzerland-general
Switzerland
Highbridge
Somerset
United-states

MHRA approves Santhera's Duchenne muscular dystrophy drug Agamree

MHRA approves Santhera's Duchenne muscular dystrophy drug Agamree
pmlive.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pmlive.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
United-states
America
Shabir-hasham
European-commission
National-institute-for-health
Regulatory-agency
Drug-administration
America-to-catalyst-pharmaceuticals
Santhera-pharmaceutical-agamree
National-institute
Care-excellence

MHRA approves 'safer' medicine alternative for rare disease

MHRA approves 'safer' medicine alternative for rare disease
europeanpharmaceuticalreview.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from europeanpharmaceuticalreview.com Daily Mail and Mail on Sunday newspapers.

United-kingdom
Germany
Shabir-hasham
European-commission
Santhera-pharmaceuticals
Regulatory-agency
United-kingdom-medicines
Chief-medical-officer
Chief-executive
Duchenne-united-kingdom
Alex-johnson
Joining-jack

Santhera Receives Approval for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy in the United Kingdom

Santhera Receives Approval for AGAMREE® (Vamorolone) as a Treatment for Duchenne Muscular Dystrophy in the United Kingdom
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United-states
Pratteln
Switzerland-general
Switzerland
Germany
United-kingdom
Swiss
America
Eva-kalias
Shabir-hasham
Life-science-alliance
European-union